Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...
TNG260 is a first-in-class, highly selective CoREST complex inhibitor currently being evaluated with pembrolizumab in the dose expansion phase of the TNG260 Phase 1/2 trial. The trial is currently ...
ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease – – ARV-102 ...
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced one late-breaker oral platform presentation and two poster ...
SAN FRANCISCO, Feb. 11, 2025 /PRNewswire/ -- The vast majority of clinical data abstractors believe AI would save them time, effort and cost, but concerns about data quality without human oversight ...
Leading healthcare data abstraction company evolves brand to better represent comprehensive clinical registry expertise across all medical specialties. While we built our reputation on exceptional ...
The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback